SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,944.28 -12.99
( -0.02%)

Global Indices

Nasdaq

53,227.35 -353.64
(-0.66%)

Dow Jones

7,711.10 -21.66
(-0.28%)

Hang Seng

66,431.13 119.20
(0.18%)

Nikkei 225

10,792.77 -31.49
(-0.29%)

Forex

USD-INR

95.47 -0.01
(-0.01%)

EUR-INR

110.57 -0.67
(-0.60%)

GBP-INR

129.19 -0.55
(-0.42%)

JPY-INR

0.60 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

394.8213477

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

37.32

97238.87

EPS(TTM)

Face Value()

Div & Yield %

45.29

0.24

Back

Muthoot Finance consolidated net profit rises 38.83% in the June 2026 quarter

Aug 01,2026

Net profit of Muthoot Finance rose 38.83% to Rs 2799.07 crore in the quarter ended June 2026 as against Rs 2016.20 crore during the previous quarter ended June 2025. Sales rose 34.44% to Rs 8671.60 crore in the quarter ended June 2026 as against Rs 6450.13 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	8671.60	6450.13	34
OPM %	83.76	77.95	-
PBDT	3828.53	2688.78	42
PBT	3797.13	2654.03	43
NP	2799.07	2016.20	39

76,944.28 -12.99 ( -0.02%)

53,227.35 -353.64 (-0.66%)

7,711.10 -21.66 (-0.28%)

66,431.13 119.20 (0.18%)

10,792.77 -31.49 (-0.29%)

95.47 -0.01 (-0.01%)

110.57 -0.67 (-0.60%)

129.19 -0.55 (-0.42%)

0.60 0.00 (-0.48%)